论文部分内容阅读
目的观察尼莫地平治疗神经性头痛的疗效及安全性。方法对西峡县人民医院2007年10月至2010年10月收治的180例神经性头痛患者给予尼莫地平40 mg,每日3次,口服,7 d为1个疗程,2个疗程结束后评价疗效。结果本组180例患者中,痊愈113例,显效41例,好转15例,无效11例,总有效率为93.9%;其中有13例用药后出现不同程度的不良反应,不良反应发生率为7.2%,其他大多数患者治疗期间无明显的不良反应发生。结论尼莫地平治疗神经性头痛疗效确切,安全性好,价格低廉,且无明显不良反应,值得临床推广应用。
Objective To observe the efficacy and safety of nimodipine in the treatment of neuropathic headache. Methods 180 patients with neuropathic headache admitted from October 2007 to October 2010 in Xixia County People’s Hospital were given nimodipine 40 mg three times a day orally for 7 days for one course of treatment. After two courses of treatment Evaluation of efficacy. Results Among the 180 patients, 113 cases were cured, 41 cases markedly improved, 15 cases improved, 11 cases ineffective, and the total effective rate was 93.9%. Among them, 13 cases showed different degrees of adverse reactions after treatment and the incidence of adverse reactions was 7.2 %, Most other patients during treatment no significant adverse reactions. Conclusion Nimodipine treatment of neuropathic headache is effective, safe, inexpensive, and no obvious adverse reactions, worthy of clinical promotion and application.